Tech Company Inital Public Offerings
Marinus Pharmaceuticals IPO
On 8/1/2014, Marinus Pharmaceuticals became a public company.
Transaction Overview
Company Name
Announced On
8/1/2014
Transaction Type
IPO
Amount
$44,600,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
170 N. Radnor Chester Rd. 250
Radnor, PA 19087
USA
Radnor, PA 19087
USA
Phone
Website
Email Address
Overview
Marinus Pharmaceuticals (NASDAQ: MRNS) is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Braunstein
Chief Financial Officer
Edward Smith
Chief Medical Officer
Joe Hulihan
VP - Bus. Development
Thomas Lyons
VP - Manufacturing
David Czekai
VP - Regulatory Affairs
Kimberly McCormick
Browse more venture capital transactions:
Prev: 8/1/2014: Resy venture capital transaction
Next: 8/1/2014: Webtalk venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs